Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Passive roboter for slagrehabilitering: en mulighetsstudie

7. november 2026 oppdatert av: Chandramouli Krishnan, University of Michigan

Passive roboter for slagrehabilitering

The purpose of this study is to examine the feasibility and effectiveness of a novel, multimodal approach that combines passive devices with noninvasive neuromuscular stimulation for upper extremity rehabilitation after stroke.

Studieoversikt

Status

Rekruttering

Forhold

Detaljert beskrivelse

About 800,000 individuals suffer from a stroke every year in the United States. The majority of stroke survivors often experience lingering deficits in upper extremity function. High-end robotic devices can improve outcomes and clinical productivity; however, these devices are expensive and bulky, making them not practical for many clinical or home environments. This study aims to evaluate the feasibility of low-cost non-motorized devices for stroke rehabilitation in a long-term intervention. The intervention will involve training with a table-top, semi-passive (i.e., no motors) exercise equipment called SepaRRo and commonly-used neuromuscular stimulation. The stimulation will be provided during functional activities using a custom controller (NeuRRoFES) to trigger stimulation. These instruments are designed to provide flexible, compliant assistance/resistance to improve upper extremity function and can be used in a home setting. The study will measure technical feasibility (e.g., qualitative survey, adherence, time on task, retention, ability to perform tasks) as well as clinical feasibility (i.e., changes in biomechanical, neurophysiological, and functional measures) of an intervention with these devices in stroke survivors. The findings aim to support the development of affordable, home-use rehabilitation systems for stroke patients.

Studietype

Intervensjonell

Registrering (Antatt)

4

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

  • Navn: Chandramouli Krishnan, PT, PhD
  • Telefonnummer: 7349364031
  • E-post: mouli@umich.edu

Studer Kontakt Backup

Studiesteder

    • Michigan
      • Ann Arbor, Michigan, Forente stater, 48108
        • Rekruttering
        • University of Michigan - NeuRRo Lab
        • Hovedetterforsker:
          • Chandramouli Krishnan, PT PhD
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år til 75 år (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria:

  • Age 18 to 75 years;
  • Ischemic or hemorrhagic stroke confirmed by CT, MRI, or clinical criteria;
  • No major deficits of sensation or proprioception;

Exclusion Criteria:

  • Bilateral stroke
  • Unable to think clearly and remember (Mini-Mental State Exam score < 22 and miniMOCA < 8);
  • Uncontrolled Diabetes or Hypertension;
  • Severe limitations of joint range of motion that will lead to inability of testing
  • Severe spasticity and joint contractures that will lead to inability of testing
  • Complete paresis with no possible movements
  • Severe aphasia
  • Any other medical condition that will significantly impact the study results
  • Unable to obtain reliable motor evoked potentials
  • Are pregnant or are actively trying to conceive
  • Have a recent history of repeated fainting spells or syncope.
  • Have a recent history of seizure (epilepsy) while on anti-seizure medication
  • Have a recent history of skull fracture/head injury
  • Have metal implants in the skull
  • Have cardiac pacemakers

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Enhetens gjennomførbarhet
  • Tildeling: N/A
  • Intervensjonsmodell: Enkeltgruppeoppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Robotic Intervention

Participants will receive upper extremity rehabilitation using SepaRRo and NeuRRoFES 2-5 times per week for 2-6 weeks

Participants will perform functional movements (e.g., reach for targets) with their extremities. During movements, the devices will be used to assist or resist their motion. Participants may receive biofeedback of their movements to better engage them in training. Participants may receive assistance from the devices (including neuromuscular stimulation) and/or their less-impaired limb.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Device Survey For Feasibility
Tidsramme: Post-intervention (immediately following last session of intervention)

Subjective feedback regarding feasibility of the device for training

Post-intervention (immediately following last session of intervention)

Andre resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Retention
Tidsramme: Post-intervention (immediately following last session of intervention)

Measure of how many participants completed intervention

Post-intervention (immediately following last session of intervention)
Adherence
Tidsramme: Post-intervention (immediately following last session of intervention)

Measure of percentage of sessions completed

Post-intervention (immediately following last session of intervention)
Upper extremity Fugl-Meyer Score
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively.

Changes in upper extremity Fugl-Meyer score from before the intervention (from baseline) to after its completion using publicly available scoring sheets. The Fugl-Meyer score is a measure of functional impairment and runs from 0 to 66 points, with higher numbers reflecting better outcome.

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively.
Reachable workspace
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Changes in reachable workspace from before the intervention (from baseline) to after its completion). The reachable workspace area will be measured with SepaRRo obtained from optical encoders mounted in the device.

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
Voluntary hand opening
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Changes in voluntary ability to open the hand from before the intervention (from baseline to after its completion). Voluntary hand opening will be measured with motion capture equipment.

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
Action Research Arm Test Score
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Changes in the Action Research Arm Test Score from before the intervention (from baseline) to after its completion using publicly available scoring sheets. The Action Research Arm Test is a measure of arm functional ability and runs from 0 to 57 points, with higher numbers reflecting better outcome.

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
Box and Block (BBT)
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Changes in functional measure of arm disability (BBT) from before the intervention (from baseline) to after its completion using publicly available scoring sheets.

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
Hand Strength
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Changes in force produced by the hand from before the intervention (from baseline) to after its completion as measured by force production recorded with a dynamometer

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
Arm strength
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Changes in force produced by the arm from before the intervention (from baseline) to after its completion as measured by force production recorded with a dynamometer

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
Muscle coordination
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Changes in muscle coordination of the upper extremity muscles as measured using surface electromyography between before the intervention (from baseline) to after its completion.

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
Joint coordination
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Changes in coordination of the upper extremity joints as measured motion capture between before the intervention (from baseline) to after its completion.

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively
Corticospinal excitability
Tidsramme: Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Changes in corticospinal excitability of the upper extremity muscles as measured using surface electromyography and transcranial magnetic stimulation between before the intervention (from baseline) to after its completion

Baseline and post-intervention measurements will be taken on separate days, within a week of the first and last sessions of the intervention, respectively

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: Chandramouli Krishnan, PT, PhD, University of Michigan

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

5. november 2025

Primær fullføring (Antatt)

1. oktober 2027

Studiet fullført (Antatt)

1. oktober 2027

Datoer for studieregistrering

Først innsendt

15. oktober 2025

Først innsendt som oppfylte QC-kriteriene

16. oktober 2025

Først lagt ut (Faktiske)

20. oktober 2025

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

10. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

7. november 2026

Sist bekreftet

1. november 2026

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere